US EditionApac biotech sector could draw capital as investors seek diversification amid US-China tensions
Summary by Business Times
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.2 Articles
2 Articles
Report: investors favor APAC markets as Biotech destinations amid US-China tensions
Markets in Asia Pacific (APAC) are rapidly gaining ground as credible innovation hubs amid the reshaping of global biotech strategies, driven by geopolitical tensions and significant US research funding cuts, a new report revealed on Thursday. According to the report from Bain & Company, developed in partnership with the Agency for Science, Technology and Research (A*STAR), the Singapore Economic Development Board (EDB), J.P. Morgan and SG Growt…
Coverage Details
Total News Sources2
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
